A LysM-Cre/floxed IKK2 transgenic, resulting in deletion of IKK2 in cells of the myeloid lineage (macrophages and granulocytes), led to a reduction in colon tumor incidence and size in a colitis-associated cancer model [17]. Here, IKBKB is linked to cancer.